期刊文献+

三种玻璃体视网膜疾病玻璃体液中MMP-9的定量检测 被引量:4

Investigation on the vitreous concentration of MMP-9 in patients with three kinds of vitreoretinal diseases
下载PDF
导出
摘要 目的通过检测增生型糖尿病视网膜病变(PDR)、增生性玻璃体视网膜病变(PVR)和急性视网膜坏死(ARN)患者玻璃体中MMP-9的质量浓度,探讨该分子在病变中的作用。方法采用酶联免疫吸附法检测13例PDR患者,15例PVR患者和5例ARN患者玻璃体中MMP-9的质量浓度,以单纯孔源性视网膜脱离(RD)患者作为对照。结果玻璃体中MMP-9的质量浓度PDR组为(2.10±0.51)ng/mL,PVR组为(1.61±0.22)ng/mL,ARN组为(4.00±0.49)ng/mL,与RD组(1.37±0.11)ng/mL相比,差异均有统计学意义(P<0.01)。结论三种玻璃体视网膜疾病患者玻璃体中MMP-9的质量浓度都显著升高,提示MMP-9可能在病变中起一定的作用。 Objective The function of matrix metalloproteinases (MMPs) is to degrade various components of the extracellular matrix ( ECM ) and play an important role in angiogenesis. This study was to investigate the concentration of matrix metalloproteinases-9(MMP-9) in three kinds of vitreoretinopathies and explored its role in pathogenesis of these diseases. Methods Vitrectomy was performed in 13 patients with the V stage of proliferative diabetic retinopathy (PDR) , 15 patients with proliferative vitreoretinopathy (PVR) and 5 patients with acute retinal necrosis ( ARN ) , and 19 patients with rhegmatogenous detachment of retina (RD) without PVR were used as control. The concentrations of MMP-9 in vitreous samples from surgery were detected using Enzyme linked immunosorbent assay (ELISA). Results Concentration of MMP-9 in vitreous was (2. 10 ± 0.51 ) ng/mL in PDR patients, ( 1.61 ±0. 22 ) ng/mL in PVR patients and (4.00±0.49 ) ng/mL in ARN patients, showing a significant increase in comparison with that in RD patients ( 1.37 ± 0. 11 ) ng/mL(P 〈 0.01 ). Conclusion Level of MMP-9 in vitreous elevated in three kinds of vitreoretinopathies mentioned above, suggesting that MMPs play an important role in pathogenesis of these diseases.
出处 《眼科研究》 CSCD 北大核心 2008年第5期387-389,共3页 Chinese Ophthalmic Research
基金 安徽省教育厅自然科学研究项目资助(2006KJ078C)
关键词 增生型糖尿病视网膜病变 增生性玻璃体视网膜病变 急性视网膜坏死 基质金属蛋白酶 酶联免疫吸附法 proliferative diabetic retinopathy proliferative vitreoretinopathy acute retinal necrosis matrix metalloproteinases enzyme linked immunosorbent assay
  • 相关文献

参考文献3

二级参考文献23

  • 1[3]Webster L,Chignell AH,Limb GA.Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membrances of proliferative vitreoretinopathy.Exp Eye Res,1999,68∶91
  • 2[4]Abu El-Asrar AM,Dralands L,Veckeneer M,et al.Gelatinase B in proliferative vitreoretinal disorders.Am J Ophthalmol,1998,125∶844
  • 3[5]Sato H,Takino T.A matrix metalloproteinase expressed on the surface of invasive tumour cell.Nature,1994,370∶61
  • 4[6]Plantner JJ,Jiang C,Smine A.Increase in interphotoreceptor matrix gelatinase A(MMP-2) associated with age-related macular degeneration.Exp Eye Res,1998,67∶637
  • 5[7]Das A,Mclamore A,Song W,et al.Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.Arch Ophthalmol,1999,117∶498
  • 6[8]Hanemaaijer R,Visser H,Koolwijk P,et al.Inhibition of MMP synthesis by doxycycline and chemical modified tetracyclines(CMTs) in human endothelial cells.Adv Dent Res,1998,2∶114
  • 7[1]Machemer LM.The matrix-degrading metalloporteinase.Bioessays,1992,14∶455
  • 8[2]Alexander JP,Bradley JM,Gabourel JD,et al.Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.Invest Ophthalmol Vis Sci,1990,31∶2520
  • 9Tarlton JF, Vickery C J, Leaper D J, et al. Post surgical wound progression monitored by temporal changes in the expression of matrix metalloproteinases-9. Br J Dermatol 1997;137:506-516.
  • 10Agren MS. Gelatinase activity during wound healing. Br J Dermatol 1994;131:634-640.

共引文献16

同被引文献85

  • 1李晓玲,朱旅云,葛秀兰,王广宇,胡丽叶.血清基质金属蛋白酶9及其抑制物1与糖尿病视网膜病变的关系[J].临床内科杂志,2005,22(9):592-594. 被引量:4
  • 2王毓琴,胡维琨,张晓农,王毓林.内毒素诱导性葡萄膜炎眼中NO含量和基质金属蛋白酶-9及其组织型金属蛋白酶抑制剂-1与诱导型NO合酶的表达[J].中华眼底病杂志,2005,21(6):371-374. 被引量:2
  • 3Usui Y, Goto H. Overview and diagnosis of acute retinal necrosis syndrome. Semin Ophthalmol, 2008, 23(4): 275-283.
  • 4Urayama A, Yamada N, Sasaki TI. Unilateral acute uveitis with retinal periarteritis and detachment. Jpn J Clin Ophthalmol, 1971, 25: 607-619.
  • 5Culbertson WW, Blumenkranz MS, Haines H, et al, The acute retinal necrosis syndrome. Part 2: Histopathology and etiology. Ophthalmology, 1982, 89( 12): 1317-1325.
  • 6Kim S J, Lo WR. Acute retinal necrosis. Ophthalmology, 2008, 115(6): 1 104-1 105.
  • 7Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med, 2005, 9(2): 267-285.
  • 8Yang W, Lu J, China National Diabetes and Metabolic Disorders Study Group, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362: 1090-1101.
  • 9Nawaaz Nathoo, ManCho Ng, Christopher J, et al. The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Can J Ophthalmol, 2010, 45: 28-32.
  • 10Javadi MA, Katibeh M, Rafati N, et al. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol, 2009, 9: 12.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部